SCHEMBL3260360

SCHEMBL3260360

C=Cc1c(C(=O)OC)[nH]c2ncccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 1/20 0.49
KDM4E B2RXH2 6/20 0.42
ALDH1A1 P00352 5/20 0.40
GAA P10253 2/20 0.40
HTT P42858 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
PADI4 Q9UM07 1/20 0.40
HSD17B10 Q99714 3/20 0.39
MAPK1 P28482 1/20 0.39
AURKA O14965 1/20 0.39
PARP1 P09874 1/20 0.39
FEN1 P39748 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
USP2 O75604 1/20 0.37
TSHR P16473 1/20 0.37
ALOX15 P16050 1/20 0.37
PKM P14618 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7990805 0.87 MAP2K1 (0.50) MAP2K1KDM4EALDH1A1GAAHTT
SCHEMBL24482825 0.85 MAP2K1 (0.48) MAP2K1KDM4EALDH1A1GAAHTT
SCHEMBL16497341 0.84 AURKA (0.41) MAP2K1KDM4EALDH1A1GAAPADI4
SCHEMBL7977830 0.80 ALDH1A1 (0.59) MAP2K1KDM4EALDH1A1GAAHTT
SCHEMBL7965829 0.80 MAP2K1 (0.54) MAP2K1KDM4EALDH1A1GAAHTT
SCHEMBL28839540 0.78 MAP2K1 (0.52) MAP2K1KDM4EALDH1A1GAAHTT
SCHEMBL22746578 0.78 KDM4E (0.59) KDM4EALDH1A1GAAHTTNPSR1
SCHEMBL16496843 0.78 MAP2K1 (0.52) MAP2K1KDM4EALDH1A1GAAHTT
SCHEMBL7977591 0.78 MAP2K1 (0.52) MAP2K1KDM4EALDH1A1GAAHTT
SCHEMBL1879902 0.78 MAP2K1 (0.52) MAP2K1KDM4EALDH1A1GAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC. (US) 2011-12-22 US disclosed
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC. (US) 2011-12-22 US disclosed
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC. (US) 2011-12-22 US disclosed
WO-2010005528-A2 PYRROLOPYRIDINE CARBOXYLIC ACID DERIVATIVES IRONWOOD PHARMACEUTICALS INCORPORATED (US) 2010-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives SDHA, ALDH5A1, SDHB MAP2K1 4584/4885KDM4E 3282/4885ALDH1A1 50/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.